At CES 2026, Qualcomm Inc. (NASDAQ:QCOM) aggressively positioned itself as the central architect of the “connected edge,” providing full-stack ecosystems for IoT, robotics, and automotive sectors. Unifying IoT and Next-Gen Robotics Qualcomm is consolidating the fragmented Internet of Things market…
In the current market session, Carnival Inc. (NYSE:CUK) stock price is at $30.22, after a 1.50% drop. However, over the past month, the company's stock went up by 32.25%, and in the past year, by 44.09%. Shareholders might be interested…
Incyte Corporation (NASDAQ:INCY) on Monday shared topline results from the pivotal Phase 3 frontMIND trial of tafasitamab (Monjuvi/Minjuvi) combo as a first-line treatment for adults with newly diagnosed diffuse large B-cell lymphoma (DLBCL). The trial evaluated tafasitamab and lenalidomide in…
Macro investor Raoul Pal says Bitcoin (CRYPTO: BTC) can reignite its bull run thanks to up to $8 trillion in liquidity hitting the financial markets in the next 12 months. Why 2025 Failed Despite Perfect Setup Pal said in an…
Each trading day, Benzinga Pro features hundreds of headlines and press releases, allowing traders to access the latest market news and individual stock information. Below is a look at its most-searched tickers for 2025, along with how interest in those names…
L3Harris Technologies, Inc. (NYSE:LHX) announced on Monday that it has agreed to sell a controlling interest in its Space Propulsion and Power Systems business to AE Industrial Partners, a private investment firm focused on aerospace and national security technologies. The…
Gold and silver prices surged this week as investors digested a combustible mix of geopolitics, monetary policy expectations, and long-term fiscal concerns, creating an environment increasingly reflected in precious metals ETFs. Spot gold jumped above $4,445.8 an ounce on Monday…
Neumora Therapeutics, Inc. (NASDAQ:NMRA) on Monday shared results from its Phase 1b signal-seeking study of NMRA-511 for Alzheimer’s disease (AD) agitation. NMRA-511 demonstrated a clinically meaningful effect size in people with AD agitation. In the study, NMRA-511 demonstrated a favorable…
Deep-pocketed investors have adopted a bullish approach towards Lam Research (NASDAQ:LRCX), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such…
Crinetics Pharmaceuticals Inc. (NASDAQ:CRNX) on Monday shared topline results from the fourth cohort of its Phase 2 congenital adrenal hyperplasia (CAH) study of investigational atumelnant for CAH and adrenocorticotropic hormone (ACTH)-dependent Cushing’s syndrome. CAH is a genetic disease that affects the…